Afsaneh Shirani, MD, MSCI
Afsaneh Shirani, MD, MSCI
Verified email at unmc.edu
Title
Cited by
Cited by
Year
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis
A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ...
Jama 308 (3), 247-256, 2012
2902012
Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
E Kingwell, M Van der Kop, Y Zhao, A Shirani, F Zhu, J Oger, H Tremlett
J Neurol Neurosurg Psychiatry 83 (1), 61-66, 2012
1212012
Outcomes and recurrence rates in chronic subdural haematoma
A Amirjamshidi, M Abouzari, B Eftekhar, A Rashidi, J Rezaii, K Esfandiari, ...
British journal of neurosurgery 21 (3), 272-275, 2007
932007
Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran
A Hadadi, M Rasoulinejad, Z Maleki, M Yonesian, A Shirani, Z Kourorian
Diagnostic microbiology and infectious disease 60 (3), 301-305, 2008
762008
Characterising aggressive multiple sclerosis
S Menon, A Shirani, Y Zhao, J Oger, A Traboulsee, MS Freedman, ...
J Neurol Neurosurg Psychiatry 84 (11), 1192-1198, 2013
722013
Therapeutic advances and future prospects in progressive forms of multiple sclerosis
A Shirani, DT Okuda, O Stüve
Neurotherapeutics 13 (1), 58-69, 2016
712016
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression
P Lourenco, A Shirani, J Saeedi, J Oger, WE Schreiber, H Tremlett
Multiple Sclerosis Journal 19 (5), 577-584, 2013
522013
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009)
A Shirani, Y Zhao, E Kingwell, P Rieckmann, H Tremlett
Multiple Sclerosis Journal 18 (4), 442-450, 2012
422012
Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort
ME Karim, P Gustafson, J Petkau, Y Zhao, A Shirani, E Kingwell, C Evans, ...
American journal of epidemiology 180 (2), 160-171, 2014
342014
Evaluating the safety of β-interferons in MS: A series of nested case-control studies
HJI De Jong, E Kingwell, A Shirani, JWC Tervaert, R Hupperts, Y Zhao, ...
Neurology 88 (24), 2310-2320, 2017
262017
Beta‐interferon exposure and onset of secondary progressive multiple sclerosis
T Zhang, A Shirani, Y Zhao, ME Karim, P Gustafson, J Petkau, C Evans, ...
European journal of neurology 22 (6), 990-1000, 2015
252015
Effect of early interferon beta‐1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event
H Pakdaman, MA Sahraian, A Fallah, R Pakdaman, K Ghareghozli, ...
Acta Neurologica Scandinavica 115 (6), 429-431, 2007
242007
Serum prolactin level in patients with multiple sclerosis: A case control study.
MH Harirchian, MA Sahraian, A Shirani
Medical science monitor 12 (4), CR177-CR180, 2006
232006
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
A Shirani, H Tremlett
Journal of inflammation research 3, 115, 2010
222010
Multiple sclerosis in older adults: the clinical profile and impact of interferon beta treatment
A Shirani, Y Zhao, J Petkau, P Gustafson, ME Karim, C Evans, E Kingwell, ...
BioMed research international 2015, 2015
212015
Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies
ME Karim, P Gustafson, J Petkau, H Tremlett, ...
American journal of epidemiology 184 (4), 325-335, 2016
172016
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study
A Shirani, Y Zhao, ME Karim, J Petkau, P Gustafson, C Evans, E Kingwell, ...
European journal of neurology 21 (6), 835-844, 2014
122014
Association between beta‐interferon exposure and hospital events in multiple sclerosis
C Evans, F Zhu, E Kingwell, A Shirani, ML van der Kop, J Petkau, ...
Pharmacoepidemiology and drug safety 23 (11), 1213-1222, 2014
92014
Finger tapping impairments are highly sensitive for evaluating upper motor neuron lesions
A Shirani, BD Newton, DT Okuda
BMC neurology 17 (1), 55, 2017
82017
Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report
A Shirani, P Sun, RE Schmidt, K Trinkaus, RT Naismith, SK Song, ...
Multiple Sclerosis Journal 25 (14), 1937-1941, 2019
72019
The system can't perform the operation now. Try again later.
Articles 1–20